摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-Fluoro-4-hydroxy-6-iodoquinoline-3-carboxylic acid | 228728-29-8

中文名称
——
中文别名
——
英文名称
8-Fluoro-4-hydroxy-6-iodoquinoline-3-carboxylic acid
英文别名
8-fluoro-6-iodo-4-oxo-1H-quinoline-3-carboxylic acid
8-Fluoro-4-hydroxy-6-iodoquinoline-3-carboxylic acid化学式
CAS
228728-29-8
化学式
C10H5FINO3
mdl
——
分子量
333.058
InChiKey
RISJYMCHNBBECZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    453.1±45.0 °C(Predicted)
  • 密度:
    2.162±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration
    摘要:
    Crystallography-driven optimisation of a lead derived from similarity searching of the GSK compound collection resulted in the discovery of a series of quinoline derivatives that were highly potent and selective inhibitors of PDE4 with a good pharmacokinetic profile in the rat. Quinolines 43 and 48 have potential as oral medicines for the treatment of COPD.
    DOI:
    10.1016/j.bmcl.2009.01.045
  • 作为产物:
    参考文献:
    名称:
    Quinolines as a novel structural class of potent and selective PDE4 inhibitors: Optimisation for oral administration
    摘要:
    Crystallography-driven optimisation of a lead derived from similarity searching of the GSK compound collection resulted in the discovery of a series of quinoline derivatives that were highly potent and selective inhibitors of PDE4 with a good pharmacokinetic profile in the rat. Quinolines 43 and 48 have potential as oral medicines for the treatment of COPD.
    DOI:
    10.1016/j.bmcl.2009.01.045
点击查看最新优质反应信息

文献信息

  • Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4)
    申请人:Aston Nicola Mary
    公开号:US20080280911A1
    公开(公告)日:2008-11-13
    There are provided according to the invention novel compounds of formula (I)
    根据本发明提供了式(I)的新化合物。
  • 4-HYDROXYQUINOLINE-3-CARBOXAMIDES AND HYDRAZIDES AS ANTIVIRAL AGENTS
    申请人:Pharmacia & Upjohn Company LLC
    公开号:EP1042295B1
    公开(公告)日:2005-09-07
  • CINNOLINE COMPOUNDS AS INHIBITORS OF PHOSPHODIESTERASE TYPE IV (PDE4)
    申请人:GLAXO GROUP LIMITED
    公开号:EP1945616A1
    公开(公告)日:2008-07-23
  • [EN] CINNOLINE COMPOUNDS AS INHIBITORS OF PHOSPHODIESTERASE TYPE IV (PDE4)<br/>[FR] COMPOSES CINNOLINE UTILISES EN TANT QU'INHIBITEURS DE LA PHOSPHODIESTERASE DE TYPE IV (PDE4)
    申请人:GLAXO GROUP LTD
    公开号:WO2007045861A1
    公开(公告)日:2007-04-26
    [EN] There are provided according to the invention novel compounds of formula (I).
    [FR] La présente invention concerne des composés nouveaux de formule (I).
查看更多